Should you sell TDOC?
· Teladoc Health's stock was trading at $137.40 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, TDOC shares have decreased by 78.3% and is now trading at $29.77. View which stocks have been most impacted by COVID-19. When is Teladoc Health's next earnings date?
Why did TDOC stock drop?
Teladoc Health Inc (NYSE:TDOC) Teladoc Health Inc. 33.65. Delayed Data. As of May 13. +2.96 / +9.64%. Today’s Change. 27.38. Today ||| 52-Week Range.
Is Teladoc worth it?
The high in the last 52 weeks of Teladoc stock was 174.32. According to the current price, Teladoc is 17.08% away from the 52-week high. What are analysts forecasts for Teladoc stock?
How much does Teladoc cost without insurance?
Teladoc Health, Inc. Common Stock (TDOC) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
See more
· TDOC Teladoc $31.94 The Diagnosis of TDOC Stock Before getting into the prognosis for Teladoc, let’s take a look at the diagnosis. That is, what exactly is affecting both its operating performance,...
Is teladoc overvalued?
The Bottom Line. Teladoc's stock rode a wave of media, investor, and customer attention during the 2020 coronavirus pandemic. This caused the stock's value to more than double over the course of this year into a market capitalization that far exceeds its revenues by over 10x.
What is the forecast for Tdoc stock?
Stock Price Forecast The 24 analysts offering 12-month price forecasts for Teladoc Health Inc have a median target of 43.50, with a high estimate of 141.00 and a low estimate of 30.00. The median estimate represents a +37.09% increase from the last price of 31.73.
Will the Tdoc split?
We currently have no Split History on this stock.
Who are Tdoc competitors?
Teladoc Health's competitors Teladoc Health's top competitors include naviHealth, Lash Group, Amwell, 98point6, MDLIVE, Providence Service Corporation and Sharecare.
Is Tdoc buy or sell?
The consensus among 27 Wall Street analysts covering (NYSE: TDOC) stock is to Buy TDOC stock.
Is Tdoc stock a hold?
RSI min/max Values: [ 25 - 75 ] The Teladoc Inc stock currently holds an RSI14 at 22 and is oversold on RSI14. The stock being oversold is no guarantee for instant reaction up as some stocks may be oversold for a long time....Score -3.775.Market Cap4.586BATR (14 days)$4.81 (14.31%)
Is Teladoc a big company?
Teladoc (NYSE: TDOC) is undoubtedly the leader and largest company in the telemedicine space, expanding its reach with the acquisition of Livongo in 2020. Teladoc forecasts revenue growth of over $1 billion for fiscal 2020 with total visits expected to be between 10.4 and 10.6 million.
How good is Teladoc?
Seventy-one percent of surveyed users rated Teladoc as a whole as either very good or excellent, and 76% said the services they received were a very good or excellent value.
What company owns Teladoc?
Primary services include telehealth, medical opinions, AI and analytics, telehealth devices and licensable platform services....Teladoc Health.FormerlyTeladoc Medical Services Teladoc, Inc.Traded asNYSE: TDOC Russell 1000 componentIndustryMedical careFounded2002 in Dallas, Texas, U.S.FoundersByron Brooks Michael Gorton14 more rows
Is Teladoc Health a buy right now?
25 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Teladoc Health in the last twelve months. There are currently 11...
How has Teladoc Health's stock been impacted by COVID-19 (Coronavirus)?
Teladoc Health's stock was trading at $137.40 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health...
When is Teladoc Health's next earnings date?
Teladoc Health is scheduled to release its next quarterly earnings announcement on Wednesday, April 27th 2022. View our earnings forecast for Tela...
How were Teladoc Health's earnings last quarter?
Teladoc Health, Inc. (NYSE:TDOC) issued its earnings results on Tuesday, February, 22nd. The health services provider reported ($0.07) EPS for the...
What guidance has Teladoc Health issued on next quarter's earnings?
Teladoc Health issued an update on its FY 2022 earnings guidance on Tuesday, March, 15th. The company provided EPS guidance of $-1.600-$-1.400 for...
What price target have analysts set for TDOC?
25 brokerages have issued 12-month price objectives for Teladoc Health's stock. Their forecasts range from $67.00 to $215.00. On average, they expe...
Who are Teladoc Health's key executives?
Teladoc Health's management team includes the following people: Jason N. Gorevic , Chief Executive Officer & Director Mala Murthy , Chief Financ...
What is Jason Gorevic's approval rating as Teladoc Health's CEO?
106 employees have rated Teladoc Health CEO Jason Gorevic on Glassdoor.com . Jason Gorevic has an approval rating of 95% among Teladoc Health's em...
Who are some of Teladoc Health's key competitors?
Some companies that are related to Teladoc Health include Cano Health (CANO) , 1Life Healthcare (ONEM) , Hims & Hers Health (HIMS) , Airsculpt...
What is the ticker symbol for Teladoc?
When will Teladoc Health release its earnings?
Teladoc Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "TDOC."
What is the official website of Teladoc?
Teladoc Health is scheduled to release its next quarterly earnings announcement on Tuesday, July 27th 2021. View our earnings forecast for Teladoc Health.
What is the P/E ratio of Teladoc Health?
The official website for Teladoc Health is www.teladochealth.com.
Is Teladoc Health a buy or sell company?
The P/E ratio of Teladoc Health is -18.34, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
How much does Teladoc Health make?
Teladoc Health has received a consensus rating of Buy. The company's average rating score is 2.50, and is based on 14 buy ratings, 14 hold ratings, and no sell ratings.
Does Teladoc pay dividends?
Teladoc Health has a market capitalization of $22.35 billion and generates $1.09 billion in revenue each year. The health services provider earns $-485,140,000.00 in net income (profit) each year or ($1.13) on an earnings per share basis.
